Univest
Univest
  • Markets

BHEL Share Price Target: CLSA Retains Underperform With Rs 306 Target Even as Q1 FY27 Revenue Jumps 40%

  • July 17, 2026
  • Posted by: Ankit Jaiswal
  • Category: News
No Comments
BHEL Share Price Target

BHEL share price target Rs 306 by CLSA, underperform retained. CMP Rs 445, up 2.53% (17 Jul). Q1 FY27 revenue up 40% YoY, EBITDA margin 6.5%. Stock at 40x FY28 PE. Target implies over 31% downside.

The BHEL share price target has been retained at Rs 306 by global brokerage CLSA, which reiterated its underperform rating on BHEL even after the state-run power equipment maker reported 40 percent year on year revenue growth in Q1 FY27. The target implies a downside of over 31 percent from the current market price of Rs 445, at which the stock was trading on the NSE in early trade on 17 July 2026, up 2.53 percent.

The BHEL share price target debate centres on earnings quality. CLSA’s caution stems from the quality of the margin improvement and the stock’s expensive valuation. While the headline numbers looked strong, the brokerage flagged that a large part of the profit came from items outside the core business.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • BHEL Share Price Target: Why CLSA Stays Cautious
  • BHEL Share Price Target vs the Rally: Short Squeeze and Energy Security Theme
  • Rising Competition Adds Pressure on the BHEL Share Price Target
  • BHEL Share Price Target: What Should Investors Do
  • Conclusion
  • Frequently Asked Questions FAQs
    • What is the BHEL share price target set by CLSA?
    • Why is CLSA bearish on BHEL despite 40% revenue growth?
    • What was BHEL’s EBITDA margin in Q1 FY27?
    • What valuation does BHEL trade at?
    • Who are BHEL’s main competitors in thermal equipment?
    • What is driving the rally in BHEL stock?
    • Should I buy BHEL shares at the current price?

BHEL Share Price Target: Why CLSA Stays Cautious

The BHEL share price target of Rs 306 reflects three specific concerns raised by CLSA. The table below summarises the brokerage’s key observations from the Q1 FY27 results.

Parameter CLSA Observation
Rating Underperform (retained)
Target Price Rs 306 per share
Q1 FY27 Revenue Growth 40% YoY
EBITDA Margin 6.5%
Margin Improvement Quality 56% driven by lower other expenses, including provisions and FX gains
Other Income Share of PAT Around 45%
Valuation 40x FY28 PE, viewed as expensive

Behind the BHEL share price target of Rs 306 lies a simple concern. Q1 FY27 revenue grew 40 percent year on year, while the EBITDA margin stood at 6.5 percent. However, CLSA noted that margin expansion quality was average, with 56 percent of the improvement driven by lower other expenses, including provisions and FX gains, rather than core operational efficiency.

Around 45 percent of profit after tax came from other income, which the brokerage sees as a low quality earnings mix. In simple terms, nearly half the reported profit did not come from making and selling power equipment.

BHEL Share Price Target vs the Rally: Short Squeeze and Energy Security Theme

The gap between the market price and the BHEL share price target exists because CLSA believes the recent rally has been driven by a short squeeze and the energy security theme rather than a fundamental re-rating. India’s renewed push for thermal power capacity amid rising electricity demand has lifted sentiment across the power equipment chain, and BHEL, as the largest domestic boiler and turbine maker, has been a natural beneficiary of that narrative.

However, the brokerage argues that the stock now looks expensive at 40x FY28 estimated earnings. At that multiple, the market is pricing in flawless execution on a large order book, leaving little room for disappointment on margins or delivery timelines. This is central to why the BHEL share price target sits so far below the market price.

Consult a SEBI-Registered Investment Advisor at Univest

Rising Competition Adds Pressure on the BHEL Share Price Target

CLSA reiterates its underperform rating as Chinese companies, L&T and Thermax increase competition in thermal equipment. New thermal power tenders are attracting more bidders, which could pressure pricing and win rates for BHEL over the coming ordering cycle.

Competitive intensity matters for the BHEL share price target because the margin recovery thesis depends on better pricing in new orders. If rivals undercut on price to win marquee projects, the expected improvement in profitability could take longer than the market currently assumes.

BHEL Share Price Target: What Should Investors Do

Investors should weigh the bull and bear arguments carefully. The bull case rests on India’s thermal capacity addition plans, BHEL’s dominant domestic position, and a growing order book. The bear case, captured in the BHEL share price target of Rs 306, rests on weak earnings quality, rich valuations at 40x FY28 PE, and rising competition from Chinese players, L&T, and Thermax.

Historically, state-run capital goods stocks have seen sharp swings around ordering cycles, and brokerages have differed widely on their fair value. Investors holding the stock should track execution margins in coming quarters, while new investors should avoid chasing momentum and consult a SEBI-registered advisor before taking a position.

Download the Univest iOS App or Univest Android App to track BHEL live prices and get daily stock research.

Conclusion

CLSA has retained its underperform rating with a BHEL share price target of Rs 306, implying over 31 percent downside from the current price of Rs 445. Despite 40 percent revenue growth in Q1 FY27, the brokerage flagged that 56 percent of the margin improvement came from lower other expenses and around 45 percent of PAT came from other income, while the stock trades at an expensive 40x FY28 PE. With Chinese companies, L&T, and Thermax raising competition in thermal equipment, investors should focus on earnings quality rather than headline growth, and treat the BHEL share price target debate as a reminder to consult a SEBI-registered advisor before investing.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions FAQs

What is the BHEL share price target set by CLSA?

Ans. CLSA has retained a BHEL share price target of Rs 306 per share with an underperform rating. The target implies a downside of over 31 percent from the current market price of Rs 445.

Why is CLSA bearish on BHEL despite 40% revenue growth?

Ans. CLSA flagged weak earnings quality. About 56 percent of the margin improvement came from lower other expenses, including provisions and FX gains, and around 45 percent of profit after tax came from other income rather than core operations.

What was BHEL’s EBITDA margin in Q1 FY27?

Ans. BHEL reported an EBITDA margin of 6.5 percent in Q1 FY27, alongside revenue growth of 40 percent year on year. CLSA described the quality of the margin expansion as average.

What valuation does BHEL trade at?

Ans. According to CLSA, BHEL trades at around 40 times FY28 estimated earnings, which the brokerage considers expensive after the recent rally driven by a short squeeze and the energy security theme.

Who are BHEL’s main competitors in thermal equipment?

Ans. CLSA highlighted rising competition from Chinese companies, L&T, and Thermax in thermal power equipment, which could pressure BHEL’s pricing and order win rates in upcoming tenders.

What is driving the rally in BHEL stock?

Ans. CLSA believes the recent rally has been driven by a short squeeze and the energy security theme, as India pushes for fresh thermal power capacity amid rising electricity demand.

Should I buy BHEL shares at the current price?

Ans. CLSA’s underperform rating suggests caution at current levels, though other analysts may differ. Evaluate earnings quality, competition, and valuations, and consult a SEBI-registered advisor before investing.



News
Author: Ankit Jaiswal
Ankit Jaiswal is the Senior Research Analyst at Univest, leading the platform's in-house equity research desk and serving as the editorial reviewer for all research and blog content published at univest.in. With 11+ years of experience in Indian equity markets, he oversees stock recommendations, earnings analysis, sector coverage, and ensures every published article meets SEBI Research Analyst Regulations. He holds a Bachelor of Commerce (B.Com) from St. Xavier's College, Kolkata — one of India's most prestigious commerce institutions — and has cleared CMT Level 2 from the CMT Association, a globally recognised certification in technical analysis and market research. His research methodology combines fundamental analysis (earnings quality, balance sheet strength, management commentary) with advanced technical analysis (chart patterns, momentum indicators, market structure) — giving Univest's retail investors a dual-lens approach that most Indian research platforms lack. Ankit is among the most comprehensively certified analysts in Indian financial media, holding five NISM certifications: Series-XV (Research Analyst), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-VI (Depository Operations), and Series-V-A (Mutual Fund Distributors). At Univest — India's SEBI-registered research and advisory platform — Ankit's responsibilities include leading the research team, finalising stock recommendations published across Pro Lite, Pro Super, and Pro Gold advisory services, and maintaining editorial oversight of all YMYL financial content published on the blog.

Leave a Reply Cancel reply